{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:36:13Z","timestamp":1792629373543,"version":"4.5.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2017,5,5]],"date-time":"2017-05-05T00:00:00Z","timestamp":1493942400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1050286"],"award-info":[{"award-number":["APP1050286"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2017.00223","type":"journal-article","created":{"date-parts":[[2017,5,5]],"date-time":"2017-05-05T04:51:30Z","timestamp":1493959890000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Topical Ophthalmic Formulation of Trichostatin A and SurR9-C84A for Quick Recovery Post-alkali Burn of Corneal Haze"],"prefix":"10.3389","volume":"8","author":[{"given":"Kislay","family":"Roy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad","family":"Neerati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun Hei Antonio","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupinder K.","family":"Kanwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajat","family":"Sandhir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagat R.","family":"Kanwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,5,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/sj.bjp.0707166","article-title":"HDAC inhibitors as anti-inflammatory agents.","volume":"150","author":"Adcock","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/471642","article-title":"Corneal epithelial wound healing promoted by verbascoside-based liposomal eyedrops.","volume":"2014","author":"Ambrosone","year":"2014","journal-title":"BioMed Res. Int."},{"key":"B3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.5005\/jp\/books\/11349_18","article-title":"\u201cChemical injuries to the cornea,\u201d in","author":"Asbell","year":"2011","journal-title":"Atlas and Text of Corneal Pathology and Surgery"},{"key":"B4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jneuroim.2010.06.024","article-title":"Proliferative and protective effects of SurR9-C84A on differentiated neural cells.","volume":"227","author":"Baratchi","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jneuroim.2010.10.036","article-title":"Novel survivin mutant protects differentiated SK-N-SH human neuroblastoma cells from activated T-cell neurotoxicity.","volume":"233","author":"Baratchi","year":"","journal-title":"J. Neuroimmunol."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015865","article-title":"Survivin mutant protects differentiated dopaminergic SK-N-SH cells against oxidative stress.","volume":"6","author":"Baratchi","year":"","journal-title":"PLoS ONE"},{"key":"B7","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.tiv.2015.01.007","article-title":"Evaluation of nanoformulated therapeutics in an ex-vivo bovine corneal irritation model.","volume":"29","author":"Bhasker","year":"2017","journal-title":"Toxicol. In Vitro"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009379.pub2","article-title":"Amniotic membrane transplantation for acute ocular burns.","volume":"9","author":"Clare","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3109\/02713683.2012.700756","article-title":"Structural and functional alteration of corneal epithelial barrier under inflammatory conditions.","volume":"37","author":"Contreras-Ruiz","year":"2012","journal-title":"Curr. Eye Res."},{"key":"B10","first-page":"3199","article-title":"IL-8 gene expression in cultures of human corneal epithelial cells and keratocytes.","volume":"34","author":"Cubitt","year":"1993","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B11","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1182\/blood.V77.8.1627.1627","article-title":"Interleukin-1 and interleukin-1 antagonism.","volume":"77","author":"Dinarello","year":"1991","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/ICU.0b013e32833a8da2","article-title":"Management of ocular thermal and chemical injuries, including amniotic membrane therapy.","volume":"21","author":"Fish","year":"2010","journal-title":"Curr. Opin. Ophthalmol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/978-0-387-74901-3_13","article-title":"\u201cThe conjunctival barrier in ocular drug delivery,\u201d in","author":"Gukasyan","year":"2008","journal-title":"Drug Absorption Studies: Biotechnology: Pharmaceutical Aspects"},{"key":"B14","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1136\/bjo.2009.173724","article-title":"Comparison of prognostic value of Roper Hall and Dua classification systems in acute ocular burns.","volume":"95","author":"Gupta","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s12272-009-1418-4","article-title":"Anti-inflammatory effect of Trichostatin-A on murine bone marrow-derived macrophages.","volume":"32","author":"Han","year":"2009","journal-title":"Arch. Pharm. Res."},{"key":"B16","first-page":"3320","article-title":"Expression of collagen I, smooth muscle alpha-actin, and vimentin during the healing of alkali-burned and lacerated corneas.","volume":"34","author":"Ishizaki","year":"1993","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1016\/S0886-3350(01)01141-5","article-title":"Relation between corneal haze and transforming growth factor-\u03b21 after photorefractive keratectomy and laser in situ keratomileusis.","volume":"27","author":"Kaji","year":"2001","journal-title":"J. Cataract Refract. Surg."},{"key":"B18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/nar\/gki177","article-title":"The histone deacetylase inhibitor trichostatin A alters the pattern of DNA replication origin activity in human cells.","volume":"33","author":"Kemp","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/00004397-197919020-00011","article-title":"Recurrent corneal erosion: pathogenesis and therapy.","volume":"19","author":"Kenyon","year":"1979","journal-title":"Int. Ophthalmol. Clin."},{"key":"B20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S0161-6420(82)34860-5","article-title":"Decision-making in the therapy of external eye disease: noninfected corneal ulcers.","volume":"89","author":"Kenyon","year":"1982","journal-title":"Ophthalmology"},{"key":"B21","first-page":"610","article-title":"Inflammatory mechanisms in corneal ulceration.","volume":"83","author":"Kenyon","year":"1985","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"B22","first-page":"2964","article-title":"Therapeutic potential of trichostatin A to control inflammatory and fibrogenic disorders of the ocular surface.","volume":"16","author":"Kitano","year":"2010","journal-title":"Mol. Vis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.bbamem.2007.10.018","article-title":"Structure and function of claudins.","volume":"1778","author":"Krause","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"B24","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1006\/exer.1999.0790","article-title":"Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization.","volume":"70","author":"Kvanta","year":"2000","journal-title":"Exp. Eye Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1006\/exer.2001.1054","article-title":"Regulation of MMP-9 production by human corneal epithelial cells.","volume":"73","author":"Li","year":"2001","journal-title":"Exp. Eye Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.2147\/OTT.S101209","article-title":"Delivery of a survivin promoter-driven antisense survivin-expressing plasmid Dna as a cancer therapeutic: a proof-of-concept study.","volume":"9","author":"Lin","year":"2016","journal-title":"Onco Targets Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/labinvest.2014.85","article-title":"TRPA1 is required for TGF-beta signaling and its loss blocks inflammatory fibrosis in mouse corneal stroma.","volume":"94","author":"Okada","year":"2014","journal-title":"Lab. Invest."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3109\/02713683.2013.811259","article-title":"Bovine lactoferrin promotes corneal wound healing and suppresses IL-1 expression in alkali wounded mouse cornea.","volume":"38","author":"Pattamatta","year":"2013","journal-title":"Curr. Eye Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1365-2133.2006.07642.x","article-title":"Tight junction components occludin, ZO-1, and claudin-1,-4 and -5 in active and healing psoriasis.","volume":"156","author":"Peltonen","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"B30","first-page":"559","article-title":"Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: role in PLGA nanoparticle endocytosis.","volume":"9","author":"Qaddoumi","year":"2003","journal-title":"Mol. Vis."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00226","article-title":"Ophthalmic combination of SurR9-C84A and trichostatin-A targeting molecular pathogenesis of alkali burn.","volume":"7","author":"Roy","year":"2016","journal-title":"Front. Pharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000267645","article-title":"Type IV collagen in the basement membrane of the corneal epithelium after alkali burns in guinea pigs.","volume":"27","author":"Saika","year":"1995","journal-title":"Ophthalmic Res."},{"key":"B33","first-page":"728","article-title":"Production of IL-6 and IL-1 alpha by human corneal epithelial cells.","volume":"95","author":"Sakamoto","year":"1991","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"B34","article-title":"Anti-Inflammatory and Chondroprotectivity of Dominant-Negative Survivin and Nutraceuticals, Lactoferrin and Herbs.","author":"Samarasinghe","year":"2013"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1167\/iovs.08-2919","article-title":"Trichostatin A inhibits corneal haze in vitro and in vivo.","volume":"50","author":"Sharma","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4103\/0974-620X.116624","article-title":"Ocular chemical injuries and their management.","volume":"6","author":"Singh","year":"2013","journal-title":"Oman J. Ophthalmol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1076\/ceyr.16.7.670.5057","article-title":"Cytokine expression in the alkali-burned cornea.","volume":"16","author":"Sotozono","year":"1997","journal-title":"Curr. Eye Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1007\/s11095-015-1664-8","article-title":"Nanoformulated mutant SurR9-C84A: a possible key for Alzheimer\u2019s and its associated inflammation.","volume":"32","author":"Sriramoju","year":"2017","journal-title":"Pharm. Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"495","DOI":"10.2217\/nnm.15.205","article-title":"Ultra-small algal chitosan ocular nanoparticles with iron-binding milk protein prevents the toxic effects of carbendazim pesticide.","volume":"11","author":"Sunkireddy","year":"2016","journal-title":"Nanomedicine"},{"key":"B40","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0039-6257(96)00007-0","article-title":"Chemical injuries of the eye: current concepts in pathophysiology and therapy.","volume":"41","author":"Wagoner","year":"1997","journal-title":"Surv. Ophthalmol."},{"key":"B41","first-page":"1756","article-title":"EGF, EGF receptor, basic FGF, TGF beta-1, and IL-1 alpha mRNA in human corneal epithelial cells and stromal fibroblasts.","volume":"33","author":"Wilson","year":"1992","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1006\/exer.1996.0038","article-title":"Epithelial injury induces keratocyte apoptosis: hypothesized role for the interleukin-1 system in the modulation of corneal tissue organization and wound healing.","volume":"62","author":"Wilson","year":"1996","journal-title":"Exp. Eye Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3892\/mmr.2014.2722","article-title":"Effects of topical chondrocyte-derived extracellular matrix treatment on corneal wound healing, following an alkali burn injury.","volume":"11","author":"Yang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"B44","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.1167\/iovs.04-1330","article-title":"Plasminogen kringle 5 inhibits alkali-burn\u2013induced corneal neovascularization.","volume":"46","author":"Zhang","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"updated-by":[{"DOI":"10.3389\/fphar.2018.01434","type":"correction","label":"Correction","source":"retraction-watch","updated":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T00:00:00Z","timestamp":1545091200000},"record-id":"24572"},{"DOI":"10.3389\/fphar.2017.00427","type":"expression_of_concern","label":"Expression of concern","source":"retraction-watch","updated":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T00:00:00Z","timestamp":1498608000000},"record-id":"7173"},{"DOI":"10.3389\/fphar.2018.01434","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T00:00:00Z","timestamp":1545091200000}}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2017.00223\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T23:47:35Z","timestamp":1602028055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2017.00223\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,5]]},"references-count":44,"alternative-id":["10.3389\/fphar.2017.00223"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2017.00223","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fphar.2018.01434","asserted-by":"object"}]},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,5]]},"article-number":"223"}}